A Study of Residual Curarization Incidence in China

NCT01690338 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

6090

Enrollment

OTHER

Sponsor class

Conditions

Perioperative/Postoperative Complications
PORC (Postoperative Residual Curarization)

Interventions

DRUG: Vecuronium Bromide
DRUG: Rocuronium
DRUG: Cisatracurium

Sponsor

Peking University First Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]